SEC Form 4 · accession 0001209191-17-065283
Clearside Biomedical, Inc. · CLSD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles A. Deignan
Officer — Chief Financial Officer
Period of report
Dec 8, 2017
Accepted (ET)
Dec 12, 2017 · 7:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001539029
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $5.89 | Dec 8, 2017 | A | 96,000 | A | — | Dec 7, 2027 | Common Stock | 96,000 | 96,000 | D |
Explanation of responses
- F1One-fourth of the shares underlying this option vest on December 8, 2018 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.